Expanding a Medical Device Business Through Better Hospital Buyer Insight

A mid-sized international medical-device manufacturer wanted to strengthen sales across selected Asian healthcare markets. The company relied heavily on local distributors but had limited visibility into hospital procurement, clinician influence, distributor performance, and the service expectations shaping purchasing decisions among institutional healthcare buyers.

Sales performance varied significantly between markets, even where healthcare investment appeared strong. The client did not know whether weak results were caused by pricing, low brand awareness, poor distributor coverage, limited clinical engagement, or slow procurement processes. Management needed clearer evidence before changing partners or increasing regional investment.

We designed a B2B healthcare market research programme focused on hospital buyers, procurement structures, clinical influence, competitor positioning, and distribution performance. The engagement helped the client identify priority customer segments, understand how different stakeholders evaluated suppliers, and develop a more targeted commercial strategy for institutional healthcare markets.

We interviewed hospital managers, clinicians, procurement teams, laboratory leaders, distributors, and industry specialists. The research examined supplier-selection criteria, purchasing cycles, technical requirements, training expectations, service quality, and price sensitivity. Distributor performance was benchmarked against market coverage, customer relationships, regulatory capabilities, and post-sales support.

We recommended prioritising hospital groups with higher procedure volumes and clearer replacement demand. Sales teams should involve clinicians and technical users earlier, while distributors should receive stronger product training and measurable commercial targets. The client should also adjust its value proposition to emphasise reliability, training, technical support, and lifetime operating value.

Within 12 months, proposal conversion across priority hospital accounts increased from approximately 22% to 29%. Sales within the targeted institutional segment grew by around 11%, supported by earlier engagement with clinicians, procurement teams, and technical users. One underperforming distributor was replaced, while stronger partner expectations and sales processes improved the quality of the client’s commercial pipeline.